U.S. judge blocks new Trump abortion rule for health clinics

Published 04/26/2019, 11:06 AM
© Reuters. An exam room at the Planned Parenthood South Austin Health Center is shown in Austin

By Steve Gorman and Nate Raymond

(Reuters) - A federal judge in Washington state on Thursday blocked a Trump administration rule that would prohibit taxpayer-funded family planning clinics from referring patients to abortion providers.

The preliminary injunction bars enforcement nationwide of a policy that was due to go into effect on May 3 over the vehement objections of abortion supporters who have decried it as a "gag rule" designed to silence doctor-patient communications about abortion options.

"Today’s ruling ensures that clinics across the nation can remain open and continue to provide quality, unbiased healthcare to women," Washington state Attorney General Bob Ferguson said in a statement announcing the decision.

Washington state was a named plaintiff in the case challenging restrictions proposed by the U.S. Health and Human Services Department (HHS) to its Title X program subsidizing reproductive healthcare and family planning costs for low-income women.

Neither the White House nor HHS immediately responded to requests from Reuters for comment.

The ruling by U.S. District Judge Stanley Bastian in Yakima, in eastern Washington, capped a hearing in which oral arguments were presented by both sides.

"There is no public interest in perpetuating unlawful agency action," Bastian wrote in his ruling.

Bastian also wrote that the "Plaintiffs have presented reasonable arguments that indicate they are likely to succeed on the merits."

He said that the plaintiffs "are likely to suffer irreparable harm in the absence of a preliminary injunction."

A federal judge in Oregon earlier this week said he intended to grant a preliminary injunction in a similar but separate lawsuit brought by 20 states and the District of Columbia. Two more lawsuits challenging the Title X restrictions are pending in California and Maine.

The restrictions are aimed at fulfilling Republican President Donald Trump's campaign pledge to end federal support for Planned Parenthood, an organization that provides abortions and other health services for women under Title X.

Congress appropriated $286 million in Title X grants in 2017 to Planned Parenthood and other health centers to provide birth control, screening for diseases and other reproductive health and counseling to low-income women.

The funding is already prohibited from being used for abortions, but abortion opponents have long complained that the money in effect subsidizes Planned Parenthood as a whole.

Planned Parenthood provides healthcare services to about 40 percent of the 4 million people who rely on Title X funding annually, and the organization has argued that community health centers would be unable to absorb its patients.

Under the new rule, clinics that receive Title X funding would be barred from referring patients for abortion as a method of family planning. The regulation also would require financial and physical separation between facilities funded by Title X and those providing abortions.

© Reuters. An exam room at the Planned Parenthood South Austin Health Center is shown in Austin

Abortion opponents have argued the plan would not ban abortion counseling but would ensure that taxpayer funding does not support clinics that also perform the procedure.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.